IngentaConnect Search Results

Dendritic Cell Therapy of High-Grade Gliomas

Authors: Van Gool, Stefaan; Maes, Wim; Ardon, Hilko; Verschuere, Tina; Van Cauter, Sofie; De Vleeschouwer, Steven

Source: Brain Pathology, Volume 19, Number 4, October 2009 , pp. 694-712(19)

Translational research to identify clinical applications of hepatocyte growth factor

Authors: Ido, Akio; Tsubouchi, Hirohito

Source: Hepatology Research, Volume 39, Number 8, August 2009 , pp. 739-747(9)

A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy

Authors: Wright, A.; Hawkins, C.H.; Änggård, E.E.; Harper, D.R.

Source: Clinical Otolaryngology, Volume 34, Number 4, August 2009 , pp. 349-357(9)

Publisher: Blackwell Publishing

Current Issues in Oncology Drug Development, with a Focus on Phase II Trials

Authors: Sargent, Daniel; Taylor, Jeremy

Source: Journal of Biopharmaceutical Statistics, Volume 19, Number 3, May 2009 , pp. 556-562(7)

Publisher: Taylor and Francis Ltd

Dose response results of self complementary adeno-associated virus (AAV) vector-mediated factor IX gene transfer in non-human primates

Authors: REISS, ULRIKE; DAVIDOFF, ANDREW; GRAY, JOHN; NIENHUIS, ARTHUR; NATHWANI, AMIT

Source: Haemophilia, Volume 15, Number 2, March 2009 , pp. 635-635(1)

Publisher: Blackwell Publishing

Severe acute thrombotic exacerbation in two cases with anti-phospholipid syndrome after retreatment with rituximab in phase I/II clinical trial for refractory systemic lupus erythematosus

Authors: Suzuki, K.; Nagasawa, H.; Kameda, H.; Amano, K.; Kondo, T.; Itoyama, S.; Tanaka, Y.; Takeuchi, T.

Source: Rheumatology, Volume 48, Number 2, 10 February 2009 , pp. 198-199(2)

Publisher: Oxford University Press

Localized squamous cell carcinoma of the esophagus: bimodality or trimodality approach?

Authors: Jiang, Yixing; Kimchi, Eric; Ajani, Jaffer A

Source: Future Oncology, Volume 5, Number 2, March 2009 , pp. 157-161(5)

Publisher: Future Medicine

Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphoma

Authors: Timmerman, John; Vose, Julie; Czerwinski, Debra; Weng, Wen-Kai; Ingolia, Diane; Mayo, Martha; Denney, Dan; Levy, Ronald

Source: Leukemia and Lymphoma, Volume 50, Number 1, January 2009 , pp. 37-46(10)

Publisher: Informa Healthcare

Accelerated Partial Breast Irradiation: Where Do We Stand?

Author: Dirbas, Frederick M.

Source: Journal of the National Comprehensive Cancer Network (JNCCN), Volume 7, Number 2, February 2009 , pp. 215-225(11)

Publisher: Cold Spring Publishing, LLC

Bendamustine in the treatment of chronic lymphocytic leukemia

Author: Knauf, Wolfgang

Source: Expert Review of Anticancer Therapy, Volume 9, Number 2, February 2009 , pp. 165-174(10)

Publisher: Expert Reviews

Phase I/II Trial of Induction Chemotherapy Followed by Concurrent Chemoradiotherapy and Surgery for Locoregionally Advanced Pancreatic Cancer

Authors: Marti, Jennifer; Hochster, Howard; Hiotis, Spiros; Donahue, Bernadine; Ryan, Theresa; Newman, Elliot

Source: Annals of Surgical Oncology, Volume 15, Number 12, December 2008 , pp. 3521-3531(11)

Publisher: Springer

Anti-idiotypic antibody abagovomab in advanced ovarian cancer

Authors: Bauerschlag, Dirk O; Schem, Christian; Baumann, Klaus; Harter, Philip; Hilpert, Felix; Wagner, Uwe; Bois, Andreas du; Pfisterer, Jakobus

Source: Future Oncology, Volume 4, Number 6, December 2008 , pp. 769-773(5)

Publisher: Future Medicine

Results from phase I/II and phase II studies have demonstrated the promise of Rexin-G as a treatment for resistant soft tissue sarcoma and osteosarcoma.

Source: Inpharma, Volume 1, Number 1666, 2008-11-29 , pp. 11-11(1)

Publisher: Adis International

MDV 3100 shows promise in phase I/II trial

Source: Inpharma, Volume 1, Number 1662, 2008-11-01 , pp. 12-12(1)

Publisher: Adis International

Ras pathway activation in gliomas: a strategic target for intranasal administration of perillyl alcohol

Authors: Fonseca, Clovis; Linden, Rafael; Futuro, Débora; Gattass, Cerli; Quirico-Santos, Thereza

Source: Archivum Immunologiae et Therapiae Experimentalis, Volume 56, Number 4, August 2008 , pp. 267-276(10)

Publisher: Springer

Development of a dendritic cell-based vaccine for chronic lymphocytic leukemia

Authors: Palma, M.; Adamson, L.; Hansson, L.; Kokhaei, P.; Rezvany, R.; Mellstedt, H.; Österborg, A.; Choudhury, A.

Source: Cancer Immunology, Immunotherapy, Volume 57, Number 11, November 2008 , pp. 1705-1710(6)

Publisher: Springer

HE 3286 to be evaluated in phase I/II trial of patients with RA

Source: Inpharma, Volume 1, Number 1651, 2008-08-16 , pp. 12-12(1)

Publisher: Adis International

MMRC announces phase I/II study of HuLuc63

Source: Inpharma, Volume 1, Number 1648, 2008-07-26 , pp. 10-10(1)

Publisher: Adis International

Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: I. A randomized dose escalation and feasibility study with bi- and tri-weekly regimens

Authors: Trmper, L.; Zwick, C.; Ziepert, M.; Hohloch, K.; Schmits, R.; Mohren, M.; Liersch, R.; Bentz, M.; Graeven, U.; Wruck, U.; Hoffmann, M.; Metzner, B.; Hasenclever, D.; Loeffler, M.; Pfreundschuh, M.

Source: Annals of Oncology, Volume 19, Number 3, 31 March 2008 , pp. 538-544(7)

Publisher: Oxford University Press

Immunotherapy of Pancreatic Carcinoma

Author: Marten, Angela

Source: Reviews on Recent Clinical Trials, Volume 3, Number 2, May 2008 , pp. 121-125(5)

Publisher: Bentham Science Publishers